Work

Supplementary Data from Early Therapy Evaluation of Combined Anti–Death Receptor 5 Antibody and Gemcitabine in Orthotopic Pancreatic Tumor Xenografts by Diffusion-Weighted Magnetic Resonance Imaging

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Data from Early Therapy Evaluation of Combined Anti–Death Receptor 5 Antibody and Gemcitabine in Orthotopic Pancreatic Tumor Xenografts by Diffusion-Weighted Magnetic Resonance Imaging

DOI: 10.1158/0008-5472.22376201.v1

Authors: Hyunki Kim, Desiree E. Morgan, Donald J. Buchsbaum, Huadong Zeng, William E. Grizzle, Jason M. Warram, Cecil R. Stockard, Lacey R. McNally, Joshua W. Long, Jeffrey C. Sellers, Andres Forero, Kurt R. Zinn

Language: English

Topic: MRI in cancer diagnosis

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361244725

Cites:

Cited by:

Related to: 10